2024

  • Elizabeth Mellins dies

    Mellins, who studied autoimmune disease and co-founded a large pediatric rheumatology research network, was a tireless mentor and advocate for her field.

  • sychosis starts in two brain systems

    When the brain has trouble filtering incoming information and predicting what’s likely to happen, psychosis can result, Stanford Medicine-led research shows.

  • AI advice helps skin cancer diagnoses

    Artificial intelligence algorithms powered by deep learning improve skin cancer diagnostic accuracy for doctors, nurse practitioners and medical students in a study led by the Stanford Center for Digital Health.

  • Unexpected cells may spread COVID-19

    A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

  • Virtual biopsy shows promise

    Stanford Medicine researchers develop a new imaging method to create a cell-by-cell reconstruction of skin or other tissue without taking a biopsy.

  • Verghese to give graduation keynote

    Bestselling author and proponent of humanistic care Abraham Verghese will be the keynote speaker at the Stanford School of Medicine graduation ceremony.

  • Keto diet helps mental illness

    A small clinical trial led by Stanford Medicine found that the metabolic effects of a ketogenic diet may help stabilize the brain.

  • AI tackles antibiotic resistance

    Stanford Medicine researchers devise a new artificial intelligence model, SyntheMol, which creates recipes for chemists to synthesize the drugs in the lab.

  • One treatment improves vaccine response

    Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.

  • AI tools take on soft tissue sarcomas

    Soft tissue sarcomas are rare and difficult to treat. Machine-learning tools designed at Stanford Medicine uncover distinct cellular communities that correlate with prognosis, immunotherapy success.


2023 ISSUE 3

Exploring ways AI is applied to health care